aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Ivan Mehta
March 26, 2024
Web browsers have realized they are one of the best ways for users to access the present set of AI tools, so they are working on being the first-choice containers for that. SigmaOS, a Y Combinator-backed company, is now banking on users’ desire to utilize AI tools and pay for them as the company is releasing new features like link preview summaries, pinch-to-summarize and “look it up” browsing features.
Some of these features sound and work like rival browser Arc’s recent releases. But SigmaOS claims that its feature returns better-quality results, which is a hard metric to quantify.
The company is releasing pinch-to-summarize on desktop, which works a bit like Arc’s new mobile feature. While the feature summarizer captures sections like information, ratings, reviews, prices and photos from an Airbnb listing, it just gives a small paragraph of info for an article, which is not sufficient. Arc browser’s summarize function also had its own hiccups in terms of missing out on key information, but it worked consistently across formats.
One of the company’s co-founders, Mahyad Ghassemibouyaghchi, said that SigmaOS will adapt to different page types in the coming months and will present summaries in various formats based on the web page.
SigmaOS’ marquee feature from this release is called “Look it up.” It browses the web for a given query and makes a summary page out of the information that it finds. This is similar to Arc’s “Browse for me” function, but on desktop. One key differentiator is that users can ask follow-up questions to explore more about the topic.
Besides that, the startup is also releasing link previews on hover and automatic renaming for locked (pinned) pages.
Last year, SigmaOS released some AI-powered features such as a contextual assistant called Airis, which can answer your questions about a web page or the broader web.
At one point, the startup tried to monetize through team-based features. Now, the company is looking to monetize its AI features. It said that all users would get access to AI-powered features but for $20 per month users would get better rate limits for AI features. For $30 per month, they would get unlimited usage and the ability to choose between different models such as GPT-4, Perplexity and Claude 3 Haiku.
Separately, the company is now thinking big by aiming to release an AI-agent-like feature, which will let you use the browser in a hands-free mode. In a demo video, Ghassemibouyaghchi shows how users could clear emails or book an Airbnb by interacting with the browser with voice. This is a similar idea to the Rabbit r1 device, which aims to traverse an interface for you to complete a task.
The company is also aiming to build something called “repeatable flows,” which are automatic actions based on triggers like time. You can think of them as the If This Then That (IFTTT) of browsers, but that’s still in the concept stage.
Separately, SigmaOS’ competitor Arc, which recently raised $50 million in funding at a $550 million valuation, announced in January that it plans to build an AI agent that browses the web for you.
Ghassemibouyaghchi said that more than 100,000 users have been using their product. Until now, SigmaOS has raised $4 million from investors like LocalGlobe and Y Combinator. With this launch, the company aims to gain some traction and wants to prepare for its next raise.
View original article on techcrunch.com
Share:
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 25, 2024
Eric Schmidt-backed Augment, a GitHub Copilot rival, launches out of stealth with $252M
AI is supercharging coding — and developers are embracing it. In a recent StackOverflow poll, 44% of software engineers said that they use AI tools as part of their development processes now and 26% plan to soon. Gartner estimates that over half of organizations are currently piloting or have already deployed AI-driven coding assistants, and […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Radical thinks the time has come for solar-powered, high-altitude autonomous aircraft
Though many eyes are on space as orbit develops into a thriving business ecosystem, Radical is keeping things a little closer to the ground — but not too close. Its high-altitude, solar-powered aircraft aim to succeed where Facebook’s infamous Aquila failed by refining the tech and embracing more markets. It’s hard to believe that Facebook’s […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Don't miss our latest news and updates. Subscribe to the newsletter
More from Tech Crunch: